185 related articles for article (PubMed ID: 15751710)
1. [The activity of alpha2-macroglobulin and its forms in patients with destructive pulmonary tuberculosis].
Esmedliaeva DS; Titarenko OT; Skvortsova LA; Pavlova MV; Kondakova MN; Saposhnikova NV; Riasnianskaia TB
Probl Tuberk Bolezn Legk; 2004; (11):40-3. PubMed ID: 15751710
[TBL] [Abstract][Full Text] [Related]
2. [Clinicomorphological rationale for mediastinal lymphadenectomy in the surgical treatment of disseminated destructive pulmonary tuberculosis].
Giller DB; Papkov AV; Gedymin LE; Sigaev AT; Sadovnikova SS; Bizhanov AB; Gavrilova SA; Volynkin AV; Giller GV
Probl Tuberk Bolezn Legk; 2008; (10):21-5. PubMed ID: 19069187
[TBL] [Abstract][Full Text] [Related]
3. [Specific features of the macrophage formula of bronchoalveolar lavage in patients with destructive pulmonary tuberculosis].
Lepekha LN; Lovacheva OV; Chernichenko NV; Erokhin VV; Seĭliev AA; Volchkov VA; Rozenberg OA
Probl Tuberk Bolezn Legk; 2003; (12):17-21. PubMed ID: 15004966
[TBL] [Abstract][Full Text] [Related]
4. [Morphological characteristics of reparative processes in tuberculosis and the effect of pesticides].
Arifkhanova SI; Ibragimov MA; Volkova EV
Probl Tuberk; 1992; (5-6):41-5. PubMed ID: 1409516
[TBL] [Abstract][Full Text] [Related]
5. [Cytoflavine effect on exudative-destructive manifestations of lung tuberculosis in children and teenagers].
Volchegorskiĭ IA; Novoselov PN; Denisenko IA
Eksp Klin Farmakol; 2009; 72(4):20-4. PubMed ID: 19803365
[TBL] [Abstract][Full Text] [Related]
6. [Bone and joint tuberculosis concurrent with tuberculosis of other organs].
Yagi O; Kawabe Y; Nagayama N; Shimada M; Kawashima M; Kaneko Y; Ariga H; Ohshima N; Matsui Y; Suzuki J; Masuda K; Tamura A; Nagai H; Akagawa S; Machida K; Kurashima A; Nakajima Y; Yotsumoto H
Kekkaku; 2007 Jun; 82(6):523-9. PubMed ID: 17633120
[TBL] [Abstract][Full Text] [Related]
7. Is alpha2-macroglobulin important in female stress urinary incontinence?
Wen Y; Man WC; Sokol ER; Polan ML; Chen BH
Hum Reprod; 2008 Feb; 23(2):387-93. PubMed ID: 18077315
[TBL] [Abstract][Full Text] [Related]
8. [Some metabolic characteristics of circulating phagocytes in patients with different types of pulmonary tuberculosis].
Kaminskaia GO; Abdullaev RIu
Probl Tuberk; 2002; (3):38-42. PubMed ID: 12066535
[TBL] [Abstract][Full Text] [Related]
9. [Morphohistochemical picture of fibrous changes in pulmonary tuberculosis].
Khaĭdarly IN
Probl Tuberk; 1979 Jun; (6):51-6. PubMed ID: 461424
[No Abstract] [Full Text] [Related]
10. [Differential diagnosis of pulmonary tuberculosis and community-acquired pneumonia].
Deĭkina ON; Mishin VIu; Demikhova OV
Probl Tuberk Bolezn Legk; 2007; (1):39-42. PubMed ID: 17338353
[TBL] [Abstract][Full Text] [Related]
11. [The fibrinolytic system in the hypercoagulation syndrome in patients with pulmonary tuberculosis].
Kaminskaia GO; Martynova EV; Serebrianaia BA; Komissarova OG
Probl Tuberk Bolezn Legk; 2009; (3):51-4. PubMed ID: 19455989
[TBL] [Abstract][Full Text] [Related]
12. [Residual changes in the lungs after healing of destructive forms of tuberculosis in elderly persons].
Iashchenko BP
Probl Tuberk; 1974; (9):15-20. PubMed ID: 4410756
[No Abstract] [Full Text] [Related]
13. [Therapeutic plasmapheresis in patients with destructive pulmonary tuberculosis].
Karpova NL; Naumov VN; Shaĭkhaev AIa; Titiukhina MV; Sigaev AT; Enilenis II
Probl Tuberk Bolezn Legk; 2006; (6):14-7. PubMed ID: 16881228
[TBL] [Abstract][Full Text] [Related]
14. [Changes in human pulmonary receptors in tuberculosis, chronic pneumonia and cancer].
Kornilova ZKh; Kondratenko TIa; Stavraki ES; Solov'eva IP; Severin ES; Perel'man MI
Probl Tuberk; 1993; (3):49-52. PubMed ID: 7984595
[TBL] [Abstract][Full Text] [Related]
15. [Results of use of surfactant in complex therapy of patients with destructive pulmonary tuberculosis].
Lovacheva OV; Erokhin VV; Chernichenko NV; Evgushchenko GV; Lepekha LN; Rozenberg OA
Probl Tuberk Bolezn Legk; 2006; (10):12-7. PubMed ID: 17139825
[TBL] [Abstract][Full Text] [Related]
16. [Effects of natural protease inhibitors on hemostasis and serum proteolysis blockers in patients with pulmonary tuberculosis].
Morozova TI; Khudzik LB
Probl Tuberk; 1993; (3):27-30. PubMed ID: 7527148
[TBL] [Abstract][Full Text] [Related]
17. Differential changes in alpha2-macroglobulin and hemopexin in brain and liver in response to acute inflammation.
Saso L; Leone MG; Mo MY; Grippa E; Cheng CY; Silvestrini B
Biochemistry (Mosc); 1999 Jul; 64(7):839-44. PubMed ID: 10424910
[TBL] [Abstract][Full Text] [Related]
18. [Anatomo-pathological characteristics of intrapulmonary fibrous tissue formation during treatment of destructive forms of tuberculosis and chronic nonspecific pneumonia].
Loginov EN
Probl Tuberk; 1975; (9):74-80. PubMed ID: 1228789
[No Abstract] [Full Text] [Related]
19. Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease.
Belkowski SM; Boot JD; Mascelli MA; Diamant Z; de Garavilla L; Hertzog B; Polkovitch D; Towers M; Batheja A; D'Andrea MR
Clin Exp Allergy; 2009 Aug; 39(8):1179-86. PubMed ID: 19400896
[TBL] [Abstract][Full Text] [Related]
20. [New-onset pulmonary tuberculosis in women].
Petrenko AB; Kononenko VG
Probl Tuberk Bolezn Legk; 2008; (9):19-22. PubMed ID: 19062566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
